CasLTR2 Protéine

N° du produit ABIN1330044

Détail du produit

Antigène: CasLTR2 (CYSLTR2) (Cysteinyl Leukotriene Receptor 2 (CYSLTR2))

Type de proteíne: Recombinant

Origine: Humain

Source: Wheat germ

Application: Affinity Purification (AP)

Fonction: CYSLTR2 (Human) Recombinant Protein

Séquence: MERKFMSLQP SISVSEMEPN GTFSNNNSRN CTIENFKREF FPIVYLIIFF WGVLGNGLSI YVFLQPYKKS TSVNVFMLNL AISDLLFIST LPFRADYYLR GSNWIFGDLA CRIMSYSLYV NMYSSIYFLT VLSVVRFLAM VHPFRLLHVT SIRSAWILCG IIWILIMASS IMLLDSGSEQ NGSVTSCLEL NLYKIAKLQT MNYIALVVGC LLPFFTLSIC YLLIIRVLLK VEVPESGLRV SHRKALTTII ITLIIFFLCF LPYHTLRTVH LTTWKVGLCK DRLHKALVIT LALAAANACF NPLLYYFAGE NFKDRLKSAL RKGHPQKAKT KCVFPVSVWL RKETRV

Attributs du produit: Human CYSLTR2 full-length ORF (NP_065110.1) recombinant protein without tag.
This product is belong to Proteoliposome (PL).

Purification: in vitro wheat germ expression system with proprietary liposome technology

Information d'application

Indications d'application: Heating may cause protein aggregation. Please do not heat this product before electrophoresis.

Commentaires:

Preparation method: in vitro, wheat germ expression system with proprietary liposome technology

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 25 mM Tris-HCl of pH 8.0 containing 2 % glycerol.

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: -80 °C

Stockage commentaire: Best use within three months from the date of receipt of this protein.

Détail du antigène

Antigène: CasLTR2 (CYSLTR2) (Cysteinyl Leukotriene Receptor 2 (CYSLTR2))

Autre désignation: CYSLTR2 (CYSLTR2 Produits)

Synonymes: CYSLTR2 Protein, CYSLT2 Protein, CYSLT2R Protein, HG57 Protein, HPN321 Protein, KPG_011 Protein, hGPCR21 Protein, 2300001H05Rik Protein, Cltr2 Protein, Cyslt2 Protein, cysLT2R Protein, cysteinyl leukotriene receptor 2 Protein, CYSLTR2 Protein, Cysltr2 Protein

Sujet: Full Gene Name: cysteinyl leukotriene receptor 2
Synonyms: CYSLT2,CYSLT2R,GPCR,HG57,HPN321,KPG_011,PSEC0146,hGPCR21

ID gène: 57105

NCBI Accession: NM_020377